Abstract:Flexible manipulation of the fate of cancer cells through exogenous stimulation-induced metabolic reprogramming could handle the cellular plasticity-derived therapies resistance, which provides an effective paradigm for the treatment of refractory and relapsing tumors in clinical settings. Herein, we demonstrated that moderate heat (45 °C) could significantly regress the expression of antioxidants and trigger specific lipid metabolic reprogramming in cancer cells synergized with iron oxide nanoparticles (Fe3O4 NPs). This metabolic control behavior destroyed the tumor redox homeostasis and produced overwhelming lipid peroxides, consequently sensitizing the tumor to ferroptosis. Based on these findings, a heat-triggered tumor-specific ferroptosis strategy was proposed by the rational design of a polypeptide-modified and 1H-perfluoropentane (1H-PFP)-encapsulated Fe3O4-containing nanoformulation (3O4). When irradiated by an 808 nm laser, the phase transition of 1H-PFP was triggered by localized moderate heat (45 °C), leading to burst release of Fe3O4in situ to produce potent reactive oxygen species through the Fenton reaction in the tumor microenvironment. Together with the antioxidant inhibition response and distinctive lipid metabolic reprogramming by heat stress, this oxidative damage was amplified to induce tumor ferroptosis and achieve sufficient antitumor effects. Importantly, we confirmed that ACSBG1, an acyl-CoA synthetase, was the key pro-ferroptotic factor in this heat-induced ferroptosis process. Moreover, knockout of this gene could realize cancer cell death fate conversion from ferroptosis to non-ferroptotic death. This work provides mechanistic insights and practical strategies for heat-triggered ferroptosis in situ to reduce the potential side effects of direct ferroptosis inducers and highlights the key factor in regulating cell fate under heat stress.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c00380?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c00380</a>.Characterization and cellular targeting efficiency of 3O4 and 3O4, biodistribution of 3O4 with moderate heat, results of variation of metabolic pathways induced by Fe3O4 NPs and moderate heat, results of therapeutic effect in a water bath, results of cell viabilities with various cell death pathway inhibitors, TUNEL staining images of cells, results of detailed LPO/LP staining of tumor tissues, immunofluorescence staining of cleaved caspase-3 and TUNEL in tumor tissues, results of antitumor effect of the combination treatment on PC3 tumor, results of cell viabilities of 786-O renal cell carcinoma cells and MBA-MD-231 breast cancer cells, results of the biosafety and toxicity of 3O4 (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c00380/suppl_file/nn1c00380_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

The Sustainability of Energy Conversion Inhibition for Tumor Ferroptosis Therapy and Chemotherapy

Enhanced ferroptosis therapy with a "nano-destructor" by disrupting intracellular redox and iron homeostasis

Metal ions/nucleotide coordinated nanoparticles comprehensively suppress tumor by synergizing ferroptosis with energy metabolism interference

Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy

Spatially Asymmetric Nanoparticles for Boosting Ferroptosis in Tumor Therapy.

Tumor Microenvironment-Activatable Fe-doxorubicin Preloaded Amorphous CaCO3 Nanoformulation Triggers Ferroptosis in Target Tumor Cells

Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy

H2S-Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders.

Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells

Reactive Oxygen-Primed and Autophagy Inhibition-Sensitized Ferroptosis Combined with Photothermal Ablation for Tumor Therapy

Electron-Accepting Micelles Deplete Reduced Nicotinamide Adenine Dinucleotide Phosphate and Impair Two Antioxidant Cascades for Ferroptosis-Induced Tumor Eradication

A Metabolic Intervention Strategy for Enhanced Ferroptosis/cuproptosis Activation and Boosted Anti-Tumor Immunity

Tumor-Acidity and Bioorthogonal Chemistry Mediated Construction and Deconstruction of Drug Depots for Ferroptosis Under Normoxia and Hypoxia

Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: A prove-of-concept study of "sword and shield" theory

Nano-energy Interference: A Novel Strategy for Blunting Tumor Adaptation and Metastasis

Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy

Intracellular Mutual Promotion of Redox Homeostasis Regulation and Iron Metabolism Disruption for Enduring Chemodynamic Therapy

Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance

Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors

A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy

A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy